Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness

We aimed to evaluate the diagnostic role of Alzheimer’s disease (AD) biomarkers in tears as well as their association with retinal and choroidal microstructures. In a cross-sectional study, 35 subjects (age 71.7 ± 6.9 years) were included: 11 with prodromal AD (MCI), 10 with mild-to-moderate AD, and...

Full description

Bibliographic Details
Main Authors: Magda Gharbiya, Giacomo Visioli, Alessandro Trebbastoni, Giuseppe Maria Albanese, Mayra Colardo, Fabrizia D’Antonio, Marco Segatto, Alessandro Lambiase
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2590
_version_ 1797624276786872320
author Magda Gharbiya
Giacomo Visioli
Alessandro Trebbastoni
Giuseppe Maria Albanese
Mayra Colardo
Fabrizia D’Antonio
Marco Segatto
Alessandro Lambiase
author_facet Magda Gharbiya
Giacomo Visioli
Alessandro Trebbastoni
Giuseppe Maria Albanese
Mayra Colardo
Fabrizia D’Antonio
Marco Segatto
Alessandro Lambiase
author_sort Magda Gharbiya
collection DOAJ
description We aimed to evaluate the diagnostic role of Alzheimer’s disease (AD) biomarkers in tears as well as their association with retinal and choroidal microstructures. In a cross-sectional study, 35 subjects (age 71.7 ± 6.9 years) were included: 11 with prodromal AD (MCI), 10 with mild-to-moderate AD, and 14 healthy controls. The diagnosis of AD and MCI was confirmed according to a complete neuropsychological evaluation and PET or MRI imaging. After tear sample collection, β-amyloid peptide Aβ1-42 concentration was analyzed using ELISA, whereas C-terminal fragments of the amyloid precursor protein (APP-CTF) and phosphorylated tau (p-tau) were assessed by Western blot. Retinal layers and choroidal thickness (CT) were acquired by spectral-domain optical coherence tomography (SD-OCT). Aβ1-42 levels in tears were able to detect both MCI and AD patients with a specificity of 93% and a sensitivity of 81% (AUC = 0.91). Tear levels of Aβ1-42 were lower, both in the MCI (<i>p</i> < 0.01) and in the AD group (<i>p</i> < 0.001) when compared to healthy controls. Further, Aβ1-42 was correlated with psychometric scores (<i>p</i> < 0.001) and CT (<i>p</i> < 0.01). CT was thinner in the affected patients (<i>p</i> = 0.035). No differences were observed for APP-CTF and p-tau relative abundance in tears. Testing Aβ1-42 levels in tears seems to be a minimally invasive, cost-saving method for early detection and diagnosis of AD.
first_indexed 2024-03-11T09:40:34Z
format Article
id doaj.art-16b5d8b418294fce9bd70aafed886729
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:40:34Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-16b5d8b418294fce9bd70aafed8867292023-11-16T16:59:29ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01243259010.3390/ijms24032590Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal ThicknessMagda Gharbiya0Giacomo Visioli1Alessandro Trebbastoni2Giuseppe Maria Albanese3Mayra Colardo4Fabrizia D’Antonio5Marco Segatto6Alessandro Lambiase7Department of Sense Organs, Sapienza University of Rome, 155, Viale del Policlinico, 00161 Rome, ItalyDepartment of Sense Organs, Sapienza University of Rome, 155, Viale del Policlinico, 00161 Rome, ItalyDepartment of Human Neurosciences, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Sense Organs, Sapienza University of Rome, 155, Viale del Policlinico, 00161 Rome, ItalyDepartment of Biosciences and Territory, University of Molise, 86100 Campobasso, ItalyDepartment of Human Neurosciences, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Biosciences and Territory, University of Molise, 86100 Campobasso, ItalyDepartment of Sense Organs, Sapienza University of Rome, 155, Viale del Policlinico, 00161 Rome, ItalyWe aimed to evaluate the diagnostic role of Alzheimer’s disease (AD) biomarkers in tears as well as their association with retinal and choroidal microstructures. In a cross-sectional study, 35 subjects (age 71.7 ± 6.9 years) were included: 11 with prodromal AD (MCI), 10 with mild-to-moderate AD, and 14 healthy controls. The diagnosis of AD and MCI was confirmed according to a complete neuropsychological evaluation and PET or MRI imaging. After tear sample collection, β-amyloid peptide Aβ1-42 concentration was analyzed using ELISA, whereas C-terminal fragments of the amyloid precursor protein (APP-CTF) and phosphorylated tau (p-tau) were assessed by Western blot. Retinal layers and choroidal thickness (CT) were acquired by spectral-domain optical coherence tomography (SD-OCT). Aβ1-42 levels in tears were able to detect both MCI and AD patients with a specificity of 93% and a sensitivity of 81% (AUC = 0.91). Tear levels of Aβ1-42 were lower, both in the MCI (<i>p</i> < 0.01) and in the AD group (<i>p</i> < 0.001) when compared to healthy controls. Further, Aβ1-42 was correlated with psychometric scores (<i>p</i> < 0.001) and CT (<i>p</i> < 0.01). CT was thinner in the affected patients (<i>p</i> = 0.035). No differences were observed for APP-CTF and p-tau relative abundance in tears. Testing Aβ1-42 levels in tears seems to be a minimally invasive, cost-saving method for early detection and diagnosis of AD.https://www.mdpi.com/1422-0067/24/3/2590Alzheimer’s diseasebiomarkerstearschoroidal thicknessbeta-amyloidAPP
spellingShingle Magda Gharbiya
Giacomo Visioli
Alessandro Trebbastoni
Giuseppe Maria Albanese
Mayra Colardo
Fabrizia D’Antonio
Marco Segatto
Alessandro Lambiase
Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
International Journal of Molecular Sciences
Alzheimer’s disease
biomarkers
tears
choroidal thickness
beta-amyloid
APP
title Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
title_full Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
title_fullStr Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
title_full_unstemmed Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
title_short Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
title_sort beta amyloid peptide in tears an early diagnostic marker of alzheimer s disease correlated with choroidal thickness
topic Alzheimer’s disease
biomarkers
tears
choroidal thickness
beta-amyloid
APP
url https://www.mdpi.com/1422-0067/24/3/2590
work_keys_str_mv AT magdagharbiya betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT giacomovisioli betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT alessandrotrebbastoni betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT giuseppemariaalbanese betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT mayracolardo betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT fabriziadantonio betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT marcosegatto betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness
AT alessandrolambiase betaamyloidpeptideintearsanearlydiagnosticmarkerofalzheimersdiseasecorrelatedwithchoroidalthickness